HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of acrodermatitis continua with topical 8-methoxypsoralen plus local narrowband ultraviolet B phototherapy.

Abstract
Treatment of acrodermatitis continua of Hallopeau (ACH) is known to be difficult. A 24-year-old man presented with an 11-year history of recurrent flares of painful pustular and scaly lesions on the distal portion of his fingers and toes, with persistent nail dystrophy. Based on the clinical and histopathological findings, ACH was diagnosed. The patient was treated with topical 8-methoxypsoralen (8-MOP) without occlusion, plus local narrowband ultraviolet B (NB-UVB) phototherapy. The patient did not use any other medication between sessions except topical emollients. Ten weeks later, when the patient had received 20 sessions, almost all the lesions had cleared. We report the first case of ACH which successfully responded to treatment with 8-MOP/NB-UVB.
AuthorsSelda Pelin Kartal Durmazlar, Hatice AKPINAR, Cemile EREN, Fatma ESKIOGLU, Semih TATLICAN
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2009 Sep-Oct Vol. 19 Issue 5 Pg. 478-80 ISSN: 1167-1122 [Print] France
PMID19502154 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Methoxsalen
Topics
  • Acrodermatitis (drug therapy, pathology)
  • Administration, Topical
  • Adult
  • Humans
  • Male
  • Methoxsalen (administration & dosage)
  • Ultraviolet Therapy

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: